- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Hong Kong Pharmaceuticals & Biotech Most Popular Stocks
Results
106
Most Popular Stocks on the market
106 companies
Hansoh Pharmaceutical Group
Market Cap: HK$129.7b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$21.85
7D
0.7%
1Y
38.5%
WuXi Biologics (Cayman)
Market Cap: HK$81.8b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$20.20
7D
9.2%
1Y
51.7%
Innovent Biologics
Market Cap: HK$75.6b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$46.15
7D
9.4%
1Y
34.5%
Akeso
Market Cap: HK$75.1b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$83.70
7D
17.6%
1Y
79.0%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$65.7b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally.
6990
HK$289.00
7D
8.8%
1Y
107.2%
Sino Biopharmaceutical
Market Cap: HK$64.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$3.61
7D
6.2%
1Y
46.7%
CSPC Pharmaceutical Group
Market Cap: HK$62.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093
HK$5.43
7D
9.0%
1Y
-6.5%
WuXi XDC Cayman
Market Cap: HK$37.0b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$30.85
7D
5.5%
1Y
76.3%
China Resources Pharmaceutical Group
Market Cap: HK$30.5b
An investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.85
7D
-2.0%
1Y
1.9%
3SBio
Market Cap: HK$28.4b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.06
7D
6.9%
1Y
116.1%
Shanghai Junshi Biosciences
Market Cap: HK$26.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$14.32
7D
9.3%
1Y
47.5%
RemeGen
Market Cap: HK$23.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$34.90
7D
35.8%
1Y
28.8%
United Laboratories International Holdings
Market Cap: HK$23.3b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$12.80
7D
4.4%
1Y
33.5%
Genscript Biotech
Market Cap: HK$22.6b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.46
7D
5.4%
1Y
-9.0%
Grand Pharmaceutical Group
Market Cap: HK$19.2b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.49
7D
-6.0%
1Y
38.6%
Simcere Pharmaceutical Group
Market Cap: HK$18.9b
Engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China.
2096
HK$7.64
7D
-0.1%
1Y
48.3%
XtalPi Holdings
Market Cap: HK$18.4b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$4.58
7D
4.3%
1Y
n/a
China Medical System Holdings
Market Cap: HK$17.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.24
7D
-1.4%
1Y
2.7%
Shanghai Henlius Biotech
Market Cap: HK$17.4b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$32.00
7D
25.0%
1Y
119.8%
InnoCare Pharma
Market Cap: HK$17.3b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$8.27
7D
4.6%
1Y
85.0%
Duality Biotherapeutics
Market Cap: HK$15.6b
Duality Biotherapeutics Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$187.20
7D
n/a
1Y
n/a
Everest Medicines
Market Cap: HK$15.1b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$46.60
7D
2.1%
1Y
101.3%
Ascentage Pharma Group International
Market Cap: HK$12.6b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$36.80
7D
4.1%
1Y
118.3%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.05
7D
3.2%
1Y
-11.7%
Keymed Biosciences
Market Cap: HK$11.5b
A biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases.
2162
HK$41.65
7D
7.6%
1Y
40.0%
YiChang HEC ChangJiang Pharmaceutical
Market Cap: HK$10.4b
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
1558
HK$11.78
7D
25.9%
1Y
-7.8%
CanSino Biologics
Market Cap: HK$10.3b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$28.65
7D
0.2%
1Y
58.8%
TYK Medicines
Market Cap: HK$10.2b
A clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of therapies to address unmet medical needs in cancer treatment.
2410
HK$27.45
7D
5.4%
1Y
n/a
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.8b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.94
7D
1.0%
1Y
-55.1%
SSY Group
Market Cap: HK$8.7b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.95
7D
-3.0%
1Y
-38.8%
Shandong Xinhua Pharmaceutical
Market Cap: HK$8.4b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$5.42
7D
2.1%
1Y
2.3%
Consun Pharmaceutical Group
Market Cap: HK$7.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.54
7D
8.3%
1Y
71.9%
CK Life Sciences Int'l. (Holdings)
Market Cap: HK$7.4b
An investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America.
775
HK$0.77
7D
60.4%
1Y
126.5%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.0b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.42
7D
-2.0%
1Y
-6.8%
Luye Pharma Group
Market Cap: HK$6.8b
An investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide.
2186
HK$1.81
7D
2.3%
1Y
-31.4%
CARsgen Therapeutics Holdings
Market Cap: HK$6.8b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States.
2171
HK$12.34
7D
14.7%
1Y
174.8%